.Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AX09_Viloxazine.Viloxazine .Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AX09_Viloxazine.Viloxazine| name: | Viloxazine | |
| ATC code: | N06AX09 | route: | oral |
| compartments: | 1 | |
| dosage: | 700 | mg |
| volume of distribution: | 7.6 | L |
| clearance: | 1.32 | L/h/kg |
| other parameters in model implementation | ||
Viloxazine is a selective norepinephrine reuptake inhibitor that was originally developed and used as an antidepressant in several European countries. It is now approved by the US FDA as a non-stimulant treatment for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents.
Pharmacokinetic parameters in healthy adults after single oral administration.
De Hondt, L, et al., & Tommelein, E (2024). Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review. Frontiers in public health 12 1437328–None. DOI:10.3389/fpubh.2024.1437328 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39171321